Interazione tra farmaci : BPC-157 pu interagire con altri farmaci, pertanto importante consultare il medico
Levonorgestrel Intrauterine System (Mirena): An Emerging Tool for Conservative Treatment of Abnormal Uterine Bleeding
The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
Wheeler-Kingshott, et al
Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Description FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction, supplied as a lyophilized 10mg vial
Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles